
Iterum Therapeutics ITRM
€ 0.28
-2.23%
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Iterum Therapeutics P/S 2011-2026 | ITRM
P/S Jährlich Iterum Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 985 | 111 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 985 | 111 | 548 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Adagene
ADAG
|
35.6 | $ 1.9 | -3.11 % | $ 107 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.71 | 1.88 % | $ 17 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 25.87 | -0.79 % | $ 1.25 B | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.31 | -4.06 % | $ 7.96 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 215.29 | 4.59 % | $ 5 B | ||
|
BioNTech SE
BNTX
|
35.7 | $ 105.97 | -2.78 % | $ 27.2 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Bio-Path Holdings
BPTH
|
627 | - | - | $ 100 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Baudax Bio
BXRX
|
0.614 | - | 0.59 % | $ 63 K | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 64.74 | 1.41 % | $ 8.66 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 3.96 | -1.0 % | $ 8.62 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.63 | -0.93 % | $ 1.56 B | ||
|
CASI Pharmaceuticals
CASI
|
36.1 | $ 0.95 | -0.72 % | $ 129 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Celldex Therapeutics
CLDX
|
0.187 | $ 25.15 | -1.95 % | $ 1.62 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 14.01 | 3.7 % | $ 922 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Biogen
BIIB
|
2 | $ 164.87 | 0.27 % | $ 24 B | ||
|
Avid Bioservices
CDMO
|
3.03 | - | - | $ 789 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
4.96 | $ 23.32 | 2.71 % | $ 2.76 B | ||
|
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K |